Membership Information
Mission
Membership Guidelines
Research Membership
Research Associate Membership
Clinician Status
Senior Clinician Status
Affiliate
Membership Privileges to All Members and Affiliates
Additional Membership Privileges to Research and Research Associate Members
Additional Membership Privileges to Clinical Members
Obligations of Membership
Application Process
Review and Renewal of Applications
Siteman Cancer Center Web site and physician referral list
Definition of Peer-Reviewed Research
Mission
To reduce the impact of cancer today and eliminate the threat of cancer tomorrow.
Membership Guidelines
Membership and affiliation is open to all individuals who would like to promote the mission of the Siteman Cancer Center. Our membership and affiliation categories and specific criteria listed below have been created to better organize and facilitate the focus of our mission. Applicants must fulfill ALL requirements in the appropriate category.
Research Membership
This category is designed for individuals whose major focus is research; these members will be supported in their research efforts by the National Cancer Institute (NCI) Cancer Center Support Grant.
1. Washington University academic appointment, Barnes-Jewish Hospital appointment, St. Louis Children's Hospital appointment, Saint Louis University School of Public Health academic appointment or other individual with a professional appointment deemed appropriate by the director.
2. At least one of the following:
- Principal investigator of cancer-related, peer-reviewed, funded research. (See the bottom of this page for a definition of peer-reviewed research.)
- Named investigator/collaborator of cancer-related, peer-reviewed, funded research.
- Major contributor in the development and implementation of cancer-related institutional clinical trials and a minimum of 30 therapeutic clinical trial registrations per year.
- Principal Investigator of at least one institutional investigator-initiated clinical trial that is a.) actively accruing; b.) determined to be meritorious by the Membership Committee; and c.) a pilot, Phase I, Phase II, or Phase III therapeutic, ancillary or imaging trial (i.e., not tissue/specimen, chart review, etc.).
- Leader of a Siteman training program or a training program with a specific cancer focus.
3. Recent cancer-related publications (during the last three years) in peer-reviewed professional journals.
4. Clear commitment to participate in one or more Siteman Research Programs.
5. Utilization of core facilities (as appropriate).
Research Associate Membership
This category is designed for new investigators to advance their cancer-related research or for tenured faculty who are interested in translating their research from another field into cancer research. These members will be supported in their research efforts by the National Cancer Institute (NCI) Cancer Center Support Grant. It is fully expected that individuals assigned to this category will meet all criteria for Research Membership within two years. If not, the member will lose Research Associate privileges and be reclassified as an Affiliate.
- Washington University academic appointment, Barnes-Jewish Hospital appointment, St. Louis Children's Hospital appointment, Saint Louis University School of Public Health academic appointment or other individual with a professional appointment deemed appropriate by the director.
- Significant professional involvement in cancer research but not meeting all criteria for Research Membership.
- Clear commitment to participate in one or more Siteman Research Programs.
- Utilization of core facilities (as appropriate).
Clinicians
- Washington University full-time academic appointment, Barnes-Jewish Hospital full-time appointment, St. Louis Children's Hospital full-time appointment or other individual with a professional appointment deemed appropriate by the director. Physicians without an appropriate institutional affiliation may achieve status other than affiliate if at least 30 patients per year are enrolled in therapeutic clinical trials at Siteman.
- Significant professional involvement in cancer care and/or education.
- Clear commitment to participate in the development of the Siteman's mission.
Senior Clinicians
(By Membership Subcommittee recommendation only)
- Emeritus clinician, long-standing member of the Siteman Cancer Center, no longer eligible for Research Member status but has significant professional involvement in cancer care and/or education.
Affiliate
- Washington University faculty or nonfaculty employee, Barnes-Jewish Hospital employee, St. Louis Children's Hospital employee, Saint Louis University School of Public Health employee or other individual – regardless of institutional affiliation – who would like to be informed of Siteman activities and progress, including receiving progress reports and other official centerwide mailings.
Membership Privileges to All Members, Clinicians and Affiliates
- Members, Clinicians and Affiliates receive all Siteman publications and have access to Siteman information provided on a website (www.siteman.wustl.edu).
- Members, Clinicians and Affiliates may attend conferences, seminars and retreats sponsored by Siteman at no cost.
Additional Membership Privileges to Research and Research Associate Members
- Members have priority access and subsidized fees for shared resources and services being developed by Siteman, including:
Biomedical Informatics Core
Biostatistics Core
Clinical Trials Core
Embryonic Stem Cell Core
Biologic Therapy Core
Health Behavior, Communication and Outreach Core
Hereditary Cancer Core
High-Speed Cell Sorter Core
High-Throughput Screening Core
Imaging Response Assessment Team (IRAT)
Molecular and Genomics Analysis Core
Proteomics Core
Small Animal Cancer Imaging Core
Tissue Procurement Core
- Research and Research Associate Members appear on the Siteman website under "Research Members" and also "Treating Physicians," if appropriate.
- Research and Research Associate Members may appear on the Siteman physician referral list, if appropriate.
- Members who hold key leadership positions are potentially eligible for salary support from Siteman.
- Members may compete for Siteman developmental funds for research pilot projects.
- Members have access to administrative support in submitting research proposals for funding.
- Members are potentially eligible for Siteman laboratory or other research space.
- Members are eligible for support from graduate students through the Cancer Biology Pathway.
- Members may participate in Siteman's Summer Student Program for support of summer projects by medical students, premedical students or undergraduates pursuing a doctoral degree.
Privileges to Clinicians and Senior Clinicians
- Clinicians and senior clinicians have access to dedicated cancer center staff members in the areas of marketing and communications, outreach and patient care (psychosocial support and financial counseling).
- Clinicians and senior clinicians appear in the "Treating Physicians" section of the Siteman website.
- Clinicians and senior clinicians appear on Siteman's physician referral list.
- Clinicians and senior clinicians may participate in Siteman multidisciplinary clinics.
- Clinicians and senior clinicians may participate in Siteman's Summer Student Program for support of summer projects by medical students, premedical students or undergraduates pursuing doctoral degrees.
Obligations of Membership
(Research and Research Associate Members only)
- Members must actively participate in a research program. Participation will be defined broadly but will ideally include developing new research projects in collaboration with other program members; attendance at Siteman program meetings, sponsored conferences, seminars, etc.; and authorship of cancer-related manuscripts with other program members, etc.
| Program |
Program Leader |
| Breast Cancer Research |
Matthew Ellis, MB, BChir, PhD
Jason Weber, PhD |
| Cancer and Developmental Biology |
David Ornitz, MD, PhD
Joshua Rubin, MD, PhD |
| Tumor Immunology |
William Gillanders, MD
Robert Schreiber, PhD |
Hematopoietic Development and Malignancy
|
Daniel Link, MD
Peter Westervelt, MD, PhD |
| Cellular Proliferation |
Greg Longmore, MD
Helen Piwnica-Worms, PhD |
| Prevention and Control |
Matthew Kreuter, PhD
Mario Schootman, PhD |
| Translational and Clinical Research |
Jeffrey Moley, MD
Lee Ratner, MD, PhD |
| Oncologic Imaging |
Farrokh Dehdashti, MD
Michael Welch, PhD |
- All Washington University and/or Barnes-Jewish Hospital investigators must submit all cancer studies to the Protocol Review and Monitoring Committee (PRMC) prior to submission to the Human Research Protection Office (HRPO). The policies and procedures for the PRMC are available on the Siteman website (www.siteman.wustl.edu/prmc.aspx).
- Members must provide information on clinical trials, publications and research support and other information needed to fulfill reporting requirements to maintain Siteman's standing as an NCI-designated Cancer Center.
- Members must acknowledge use of Siteman facilities, cores, space or assistance (when appropriate) in research publications and new grant submissions.
- Members must actively participate in the preparation and implementation of a P30 Cancer Center Support Grant application and renewals to the NCI.
- As of April 7, 2008, the NIH requires investigators with a publication using Siteman (or other NIH-funded) shared resources or programs to submit (or have submitted for them) their final peer reviewed manuscripts to PubMed Central (PMC) upon acceptance of publication, to be made publicly available within 12 months of publication. Many journals automatically submit these for authors, but Washington University also has assistance available through the Becker Medical Library. Please see http://publicaccess.nih.gov/FAQ.htm#b7 or http://becker.wustl.edu/classes-consulting/specialized-expertise/nih-public-access-policy for more information.
Application Process
Siteman Cancer Center
Campus Box 8100
660 South Euclid Ave.
St. Louis, MO 63110
- Send the application and requested enclosures to the address listed above.
- An application must be received before an investigator will be listed on the "Treating Physician" section of the Siteman website or the cancer center's physician referral list.
- Applications will be reviewed by the Membership Subcommittee of Siteman's Executive Committee and the program leader of an applicant's selected program. The Membership Subcommittee will then make its recommendation to the director. Applicants will receive notification by a letter of decision indicating their type of membership. Applications will be reviewed a minimum of three times a year.
Review and Renewal of Applications
All new applications will be reviewed by the Membership Subcommittee a minimum of three times a year along with recommendations from research program leaders. Membership recommendations will then be sent to Siteman's director for approval. The director has final authority on approval, disapproval or termination of membership.
All Siteman members are required to submit an updated curriculum vitae or NIH-formatted biosketch each year.
The Membership Subcommittee will review all members a minimum of one time per year and may reassign membership categories based on current review of category criteria and member information. Members must meet all the criteria listed for new applicants in their current membership category or their membership status will be reassigned. All recommended changes will be forwarded to the Siteman director for final approval.
Siteman Cancer Center Website and Physician Referral List
In order to be listed on Siteman's website and physician referral list, an investigator or clinician first must submit an application to Siteman (see above section). No one will be included on the website or the physician referral list until this form has been submitted. At the point of submission, a physician will be added to the "Treating Physician" section of the website and the physician referral list until a decision on the application has been reached by the Membership Subcommittee. If approved, the listings will be permanent. If an applicant is not approved, the listings will be deleted. For treating physicians, only full-time Washington University School of Medicine faculty members or investigators enrolling 30 or more patients in therapeutic clinical trials at Siteman will be listed on the website and physician referral list.
Definition of Peer-Reviewed Research
To be considered a peer-reviewed project or study, the responsible reviewing/funding agency or organization should meet the general NIH standards of peer-review and funding. These include meeting three criteria:
- A peer-review system that uses primarily external reviewers and is free of conflict of interest.
- A ranking or rating system in the review process based on the scientific merit of the proposed research.
- A funding system based primarily on the peer-review ranking or rating of the research application.
Examples of peer-reviewing agencies include:
- NIH
- National Science Foundation
- Food and Drug Administration
- Environmental Protection Agency
- Howard Hughes Foundation
- American Institute for Cancer Research
- Cancer Research Foundation of America
- Agency for Health Care Policy Research
- American Foundation for AIDS Research
- Central Office of the Veterans Administration
- National Office -- American Cancer Society
- Susan G. Komen Breast Cancer Foundation
- Army, DOD, DOE, DOA and CDC cancer relevant grants equal to an NIH R01 in funding